It’s back to school season so we wanted to remind people how Epilepsy Ireland help support you, your child, and their school with their return to the classroom and provide some important information on epilepsy and school.
First and foremost, it is recommended that any child with epilepsy who could have seizures in school has an individualised Care Plan. These plans should cover:
The EMA have provided an update on their ongoing assessment of a paper on the risks of paternal exposure to valproate.
In advance of SUDEP Action Day on October 18th, we are seeking responses to an important survey aimed at understanding the awareness of SUDEP amongst the epilepsy community.
In advance of the International Epilepsy Congress, Epilepsy Ireland have called on the Government to become global leaders in regard to the implementation of the WHO Intersectoral Global Action Plan on Epilepsy and other neurological conditions.
Later this week, Wayne O'Reilly will be awarded with a Golden Light award in recognition of his contributions to epilepsy awareness!
We have issued a very important survey aimed at understanding the experiences of all those who engage with Epilepsy Ireland. Can you help us by providing your feedback?
Read about a recent development which has further amplified our longstanding campaign to improve access to the Free Travel scheme for people with epilepsy.
The Annual General Meeting of Brainwave, The Irish Epilepsy Association (trading as Epilepsy Ireland) for the year ending 31.12.22 was held on July 6th via zoom.
Last week, the Government approved the holding of an inquiry into the historical licensing and prescribing of Sodium Valproate. Read our response to this important development.
A study recently published in the medical journal Neuron, has providing further information on how cannabidiol (CBD) works to potentially prevent seizures.
CBD is a non-psychoactive component of the cannabis plant, meaning that it does not cause the ‘high’ associated with recreational use of cannabis. In recent years, numerous studies have been carried out on the use of CBD treatments in drug-resistant epilepsies – many of which have showed positive findings.